Manufacturer Profile

ADmit Therapeutics SL

Sant Feliu de Llobregat (Barcelona), Spain

VERIFIED

ADmit Therapeutics, S.L. is a company that has developed the MAP-AD® Test for the early detection of Alzheimers dementia and is currently in the commercialization stage. Alzheimers Disease (AD) is a devastating process for patients and their families and a threat to public health systems in both dev...

Products & Categories

2 products

Diagnostic Tests

ADmit Alzheimer's Early Detection Test MAP-AD Test

See all 2 products from this manufacturer

Create a free account to view the full product catalog and connect with this manufacturer.

Get Free Access →

Is This Your Company?

Claim your profile & unlock analytics

See who viewed your profile, which countries buyers come from — all in your private analytics dashboard.

Profile ViewsBuyer CountriesMarket Demand DataProduct Analytics

Claim This Profile →